Biomed Central Ltd

SHERPA: Unknown

People

  1. Panageas
    Panageas
  2. Wong
    Wong
  3. Hudis
    Hudis
  4. Norton
    Norton
  5. Postow
    Postow
  6. Solomon
    Solomon
  7. Adamow
    Adamow
  8. Ariyan
    Ariyan
  9. Brogi
    Brogi
  10. Busam
    Busam

Groups

  1. Department of Medicine (7)
  2. GSK Faculty (7)
  3. Melanoma and Immunotherapeutics Service (7)
  4. Solid Tumor Oncology Division (7)
  5. Biostatistics Service (5)
  6. Epidemiology and Biostatistics (5)
  7. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (3)
  8. Melanoma Disease Management Team (3)
  9. Population Sciences Research Program (3)
  10. Survivorship Research (3)
Search Within
  1. "Jianda Yuan"
Formats
  1. Journal Article (7)
  2. Meeting Abstract (6)
Groups
  1. Department of Medicine (7)
  2. GSK Faculty (7)
  3. Melanoma and Immunotherapeutics Service (7)
  4. Solid Tumor Oncology Division (7)
  5. Biostatistics Service (5)
  6. Epidemiology and Biostatistics (5)

More Groups

People
  1. Jianda Yuan (13)
  2. Jedd Wolchok (7)
  3. David Page (3)
  4. Katherine Panageas (3)
  5. Phillip Wong (3)
  6. Zhiwan Dong (3)

More People

Years
  1. 2016 (3)
  2. 2015 (2)
  3. 2014 (3)
  4. 2013 (3)
  5. 2011 (1)
  6. 2009 (1)
Publications
  1. Journal for ImmunoTherapy of Cancer (10)
  2. Journal of Hematology & Oncology (2)
  3. Journal of Translational Medicine (1)

Results (13)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Immune monitoring technology primer: Protein microarray ('seromics')
    Journal Article

    Yuan, J.; Wang, E.; Fox, B. A.
    Journal for ImmunoTherapy of Cancer (2016)

    Fulltext@MSK | Save
  • Novel technologies and emerging biomarkers for personalized cancer immunotherapy
    Journal Article

    Yuan, J.; Hegde, P. S.; Clynes, R.; Foukas, P. G.; Harari, A.; Kleen, T. O.; Kvistborg, P.; Maccalli, C.; Maecker, H. T.; Page, D. B.; more...
    Journal for ImmunoTherapy of Cancer (2016)

    Fulltext@MSK | Save
  • Current status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapy
    Journal Article

    Ma, W.; Gilligan, B. M.; Yuan, J.; Li, T.
    Journal of Hematology & Oncology (2016)

    Fulltext@MSK | Save
  • Pre-operative immunotherapy with tumor cryoablation (cryo) plus ipilimumab (ipi) induces potentially favorable systemic and intratumoral immune effects in early stage breast cancer (ESBC) patients
    Meeting Abstract

    Page, D. B.; Diab, A.; Yuan, J.; Dong, Z.; Soloman, S. B.; Patil, S.; Hudis, C. A.; Wolchok, J. D.; Norton, L.; McArthur, H. L.
    Journal for ImmunoTherapy of Cancer (2015)

    Fulltext@MSK | Save
  • Quantitative real-time PCR assisted cell counting (qPACC) for epigenetic - based immune cell quantification in blood and tissue
    Journal Article

    Kleen, T. O.; Yuan, J. D.
    Journal for ImmunoTherapy of Cancer (2015)

    Fulltext@MSK | Save
  • Matched T cell repertoire analysis of peripheral blood and tumor-infiltrating lymphocytes (TILs) in early stage breast cancer (ESBC) patients (pts) treated with pre-operative cryoablation (cryo) and/or Ipilimumab (Ipi)
    Meeting Abstract

    Page, D. B.; McArthur, H.; Dong, Z.; Wong, P.; Emerson, R.; Mu, Z.; Zhao, C.; Comstock, C.; Morris, E.; Comen, E.; more...
    Journal for ImmunoTherapy of Cancer (2014)

    Fulltext@MSK | Save
  • Patterns of long-term survival following Ipilimumab (Ipi): The Memorial Sloan Kettering Cancer Center 10-year metastatic melanoma (MM) experience
    Meeting Abstract

    Page, D. B.; Naidoo, J.; Momtaz, P.; Bogatch, K.; Kuk, D.; Panageas, K.; Yuan, J.; Wolchok, J. D.; Postow, M.
    Journal for ImmunoTherapy of Cancer (2014)

    Fulltext@MSK | Save
  • T cell receptor diversity evaluation to predict patient response to Ipilimumab in metastatic melanoma
    Meeting Abstract

    Postow, M.; Manuel, M.; Wong, P.; Yuan, J.; Noel, M.; Courtier, A.; Pasqual, N.; Wolchok, J. D.
    Journal for ImmunoTherapy of Cancer (2014)

    Fulltext@MSK | Save
  • Pre-treatment serum vascular endothelial growth factor is associated with clinical response and overall survival in advanced melanoma patients treated with ipilimumab
    Meeting Abstract

    Yuan, J.; Zhou, J.; Dong, Z.; Tandon, S.; Kuk, D.; Panageas, K. S.; Wong, P.; Wolchok, J. D.; Hodi, F. S.
    Journal for ImmunoTherapy of Cancer (2013)

    Fulltext@MSK | Save
  • Peripheral blood and tumor biomarkers in patients with advanced melanoma treated with combination nivolumab (anti-PD-1, BMS-936558, ONO-4538) and ipilimumab
    Meeting Abstract

    Callahan, M. K.; Horak, C. E.; Curran, M. A.; Hollman, T.; Schaer, D. A.; Yuan, J.; Lesokhin, A. M.; Kitano, S.; Hong, Q.; Ariyan, C. E.; more...
    Journal for ImmunoTherapy of Cancer (2013)

    Fulltext@MSK | Save